🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalHas anyone dealt with german private insurance (pkv) vs statutory (gkv)? Page 6

Has anyone dealt with german private insurance (pkv) vs statutory (gkv)?

B12Beth Wed, Apr 16, 2025 at 1:17 AM 36 replies 1,942 viewsPage 6 of 8
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Jul 28, 2025 at 8:03 AM#26

Adding the numbers, since they settle part of this. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

Last edited: Jul 28, 2025 at 12:03 PM
38 13josh_phd_bmore, roxy_nash, tony_orlando and 35 others
Reply Quote Save Share Report
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Aug 11, 2025 at 12:02 AM#27

One thing that is still open after NurseLeah_Nash’s answer:

What would you measure differently if you were starting again?

37 12roxy_nash, tony_orlando, Dr.NephBHM_UK and 34 others
Reply Quote Save Share Report
GraceAZ_72
Member
156
678
Jan 2025
Tucson, AZ
Aug 24, 2025 at 3:53 PM#28
TirzTom said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Pushing back on the anecdote-stacking. Twenty people reporting the same thing is twenty samples from the same self-selected pool, not twenty independent confirmations.

36 11SallyK_inj, CryptoCarl, MariaRD and 33 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
mark_tokyo
Member
456
1,890
Jun 2024
Tokyo, JP
Sep 7, 2025 at 7:36 AM#29
TirzTom said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

35 10HPLC_Greg, LibrarianMeg, bri_stats and 32 others
Reply Quote Save Share Report
B12Beth
Member
289
890
Oct 2024
Maryland
Sep 20, 2025 at 11:11 PM#30

Closing the loop on my own question.

Update: approved on the third attempt after a peer-to-peer. Nothing about my case changed; only who was doing the talking.

13 13pam_columbus, nick_SD_fit, ben_calgary and 10 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register